--

Dr. Vivek Mundada, DCH (India), DCH (UK), MRCPCH, FRCPCH, CCT (UK) is a British Board-certified consultant paediatric neurologist who has a subspecialty interest in paediatric neurodisability. He is currently working Medcare Women and Children Hospital in Dubai. He has completed his sub-specialty training in paediatric neurology and neurodisability in the UK which was recognized by the Royal College of Paediatrics and Child Health. He was trained and has worked in reputed hospitals like Great Ormond Street Hospital, London, and Addenbrookes Hospital, Cambridge in the UK.

Before moving to the UAE, he has served as a consultant paediatric neurologist in Royal London Hospital, London which is a leading, internationally renowned teaching hospital in east London. He has established the acquired brain injury unit in this hospital. His work was recognized by the House of Lords where he was honoured and was invited to give a talk on his experience.

With his initiative, two of the Spinal Muscular Atrophy children received gene therapy for the first time in the UAE in November 2020. Till date many infants with this condition from countries like Iran, Turkey, Romania, Nepal and Ethiopia have received successful gene therapy under his care.

Apart from the complex paediatric epilepsies and neurodevelopmental disorders, his areas of special interest lie in childhood headaches' and paediatric movement disorder. He serves as a faculty for the British Paediatric Neurology Association run international courses- ‘Paediatric Epilepsy Training (iPET)' and ‘Childhood Headache Training (CHaT)'.

In the areas of his interest, he has conducted and led various research projects which have been presented on various international platforms and published in peer-reviewed journals.